Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||- / 2||LA / -|
Administered by: Pharmacy Purchased by: ??
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Other Medications: ZOLOFT; GABAPENTIN
Preexisting Conditions: Medical History/Concurrent Conditions: Drug allergy (Known allergies: Macro Bid antibiotic)
Diagnostic Lab Data:
CDC 'Split Type': USPFIZER INC2021830836
Write-up: Having a difficult time breathing; This is a spontaneous report received from a contactable consumer or other non hcp. A 47-years-old female patient received second dose of bnt162b2 (PFIZER BIONTECH-COVID19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 18Jun2021 09:00 as single dose for COVID-19 immunization. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing, known allergies: Macro Bid antibiotic. Concomitant medications included sertraline hydrochloride (ZOLOFT) and gabapentin taken for an unspecified indication, start and stop date were not reported. Prior and since the vaccination, patient was not tested and diagnosed with COVID19.The patient was not hospitalized after vaccination. The patient did not received any other vaccine within 4 weeks prior to COVID-19 Vaccine. The patient experienced having a difficult time breathing (dyspnoea) on 03Jul2021.The outcome of the event was not resolved. No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166